by admin | Jul 12, 2021 | Press Release
Seattle, WA, July 15, 2021 – Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced the future expansion of its biologics manufacturing capabilities through a lease agreement to occupy a...
by admin | Jun 16, 2021 | Press Release
Seattle, WA, June 16, 2021 – Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, announced today it has entered into a research collaboration with Novo Nordisk to evaluate the use of Lumen’s unique drug...